A Macrophage Differentiation-Mediated Gene: DDX20 as a Molecular Biomarker Encompassing the Tumor Microenvironment, Disease Staging, and Prognoses in Hepatocellular Carcinoma.
Yi YangMing YangHuasheng PangYiwen QiuTing SunTao WangShu ShenWentao WangPublished in: Oxidative medicine and cellular longevity (2022)
In sum, DDX20 may serve as a prognostic marker for worse clinical outcomes with HCC and potentially enable more precise and personalized immunotherapeutic strategies in the future.